Home Drug Codes C Codes C9153 · BARHEMSYS
Updated July 1st, 2026

BARHEMSYS C Code: C9153

Injection, amisulpride, 1 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
Not published
CMS publishes none for Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
No current ASP
Not available for Q3 2026
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
2
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, amisulpride, 1 mg
HCPCS Added Date October 1, 2023
Manufacturer Acacia Pharma
Route of Administration Intravenous
Generic Status HCPCS Discontinued
Dosage Type Single-Dose
Dosage Form Injection, Solution

About BARHEMSYS

Barhemsys is a medication aligned to the HCPCS C Code: C9153 for billing, pricing, and reimbursement purposes in the United States. Classified under Anti-Emetic, it is administered via the intravenous route and manufactured by Acacia Pharma.

Manufacturers, reach out to us to add more information.

NDC Code Information

2 NDC packages are crosswalked to C9153. Package detail is available to logged-in subscribers.

Login to view 2 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

BARHEMSYS CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

BARHEMSYS Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Postoperative nausea and vomiting (PONV)
Drug Class
Dopamine D2 Antagonists [MoA]Dopamine-2 Receptor Antagonist [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Barhemsys billing and coding guide?
We have not yet identified a manufacturer source of Barhemsys billing and coding information.
Are there any available Barhemsys patient assistance programs?
Our team did not identify a source for Barhemsys patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Barhemsys prescribing information?
BARHEMSYS prescribing information can be found at the link below: Visit Here →
Where can I find Barhemsys side effect information?
Information regarding BARHEMSYS's side effects can be found at MedlinePlus Visit Here →
Does billing BARHEMSYS require JZ/JW wastage modifiers?
CMS does not include BARHEMSYS (C9153) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing C9153. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.